News Daily News Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities Caitlin E. Cox September 08, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Daily News Un Estudio del Mundo Real Confirma los Efectos de Apixaban y Rivaroxaban en el Manejo de la FA Todd Neale April 21, 2016
News Daily News Real-World Study Largely Confirms Effects of Apixaban, Rivaroxaban for A-fib Todd Neale April 21, 2016
News Daily News Good Warfarin Management Prevents Complications in A-fib Patients, Swedish Study Contends L.A. McKeown April 21, 2016
Presentation Fellows 2016 How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy Presenter: Roxana Mehran April 15, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Daily News US Cardiologists Are Underusing Oral Anticoagulation for A-fib Todd Neale March 21, 2016
News Daily News Los Cardiólogos de EE.UU. Infrautilizan la Anticoagulación Oral en el Manejo de la FA Todd Neale March 21, 2016
News Daily News Real-World Traumatic Intracranial Bleeding in Elderly, Warfarin-Treated Patients a Bigger Problem Than Seen in Trials Todd Neale March 09, 2016
News Daily News Nuevos Roles de las Clínicas Especializadas en Anticoagulación en una Era de Opciones Sin Warfarina Todd Neale March 01, 2016
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Daily News Final CMS Decision Memo for Watchman Dumps Controversial Warfarin Contraindication Shelley Wood February 08, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Industry News Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate) November 29, 2015